Table 1.

Association analysis between PRDX mRNA expression and histology of the OS in patients with lung cancer.

Gene	Affymetrix ID	Histology	HR (95% CI)	Logrank P
PRDX1	208680_at	All	1.33 (1.17-1.51)	1e-05∗∗∗∗
		Ade	1.09 (0.87-1.38)	0.46
		SCC	1.22 (0.97-1.55)	0.092
PRDX2	201006_at	All	1.25 (1.1-1.42)	0.00044∗∗∗
		Ade	1.64 (1.3-2.08)	3e-05∗∗∗∗
		SCC	1.03 (0.82-1.31)	0.78
PRDX3	209766_at	All	1.23 (1.09-1.4)	0.0012∗∗
		Ade	1.38 (1.1-1.75)	0.0058∗∗
		SCC	1.1 (0.87-1.4)	0.43
PRDX4	201923_at	All	0.99 (0.87-1.12)	0.85
		Ade	0.93 (0.74-1.17)	0.55
		SCC	0.79 (0.62-1.01)	0.055
PRDX5	222994_at	All	0.81 (0.69-0.95)	0.011∗
		Ade	0.97 (0.76-1.23)	0.8
		SCC	0.8 (0.59-1.09)	0.15
PRDX6	200844_s_at	All	1.29 (1.14-1.46)	8.7e-05∗∗∗∗
		Ade	1.75 (1.37-2.24)	5e-06∗∗∗∗
		SCC	1.16 (0.92-1.47)	0.22

All: all patients; Ade: adenocarcinoma; SCC: squamous cell carcinoma; ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001.